Compare Pfizer with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs TTK HEALTHCARE - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER TTK HEALTHCARE PFIZER/
TTK HEALTHCARE
 
P/E (TTM) x 35.9 18.4 195.2% View Chart
P/BV x 6.1 1.5 411.6% View Chart
Dividend Yield % 0.6 1.1 53.7%  

Financials

 PFIZER   TTK HEALTHCARE
EQUITY SHARE DATA
    PFIZER
Mar-19
TTK HEALTHCARE
Mar-19
PFIZER/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs3,8401,215 316.0%   
Low Rs2,080610 340.9%   
Sales per share (Unadj.) Rs455.0444.4 102.4%  
Earnings per share (Unadj.) Rs93.817.2 543.8%  
Cash flow per share (Unadj.) Rs109.427.6 395.9%  
Dividends per share (Unadj.) Rs22.505.00 450.0%  
Dividend yield (eoy) %0.80.5 138.7%  
Book value per share (Unadj.) Rs658.2177.9 369.9%  
Shares outstanding (eoy) m45.7514.13 323.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.52.1 316.8%   
Avg P/E ratio x31.652.9 59.7%  
P/CF ratio (eoy) x27.133.0 81.9%  
Price / Book Value ratio x4.55.1 87.7%  
Dividend payout %24.029.0 82.8%   
Avg Mkt Cap Rs m135,42012,894 1,050.2%   
No. of employees `0002.62.3 113.8%   
Total wages/salary Rs m3,2381,307 247.8%   
Avg. sales/employee Rs Th7,911.42,715.7 291.3%   
Avg. wages/employee Rs Th1,230.9565.3 217.7%   
Avg. net profit/employee Rs Th1,630.7105.4 1,547.1%   
INCOME DATA
Net Sales Rs m20,8156,279 331.5%  
Other income Rs m1,67478 2,159.9%   
Total revenues Rs m22,4896,356 353.8%   
Gross profit Rs m5,712496 1,152.5%  
Depreciation Rs m714147 486.6%   
Interest Rs m7334 215.7%   
Profit before tax Rs m6,599393 1,680.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,309149 1,550.4%   
Profit after tax Rs m4,291244 1,760.6%  
Gross profit margin %27.47.9 347.7%  
Effective tax rate %35.037.9 92.2%   
Net profit margin %20.63.9 531.1%  
BALANCE SHEET DATA
Current assets Rs m27,1672,717 999.8%   
Current liabilities Rs m8,9171,571 567.7%   
Net working cap to sales %87.718.3 480.2%  
Current ratio x3.01.7 176.1%  
Inventory Days Days6832 210.9%  
Debtors Days Days3047 64.5%  
Net fixed assets Rs m8,862991 894.2%   
Share capital Rs m458141 323.8%   
"Free" reserves Rs m29,6562,373 1,249.7%   
Net worth Rs m30,1132,514 1,197.7%   
Long term debt Rs m253 735.3%   
Total assets Rs m39,4004,158 947.5%  
Interest coverage x91.512.6 725.5%   
Debt to equity ratio x00 61.4%  
Sales to assets ratio x0.51.5 35.0%   
Return on assets %11.16.7 165.9%  
Return on equity %14.29.7 147.0%  
Return on capital %22.116.9 130.7%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m428225 190.2%   
Fx outflow Rs m78671 1,105.9%   
Net fx Rs m-358154 -232.4%   
CASH FLOW
From Operations Rs m978173 565.0%  
From Investments Rs m35197 363.9%  
From Financial Activity Rs m-1,099-307 357.5%  
Net Cashflow Rs m231-38 -612.2%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 3.7 202.7%  
FIIs % 4.9 5.2 94.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 25.8 91.9%  
Shareholders   85,207 12,723 669.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  STRIDES PHARMA SCIENCE  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Nov 15, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS